• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC MED REL MEDTRONIC PUERTO RICO PROTECTA VR; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC MED REL MEDTRONIC PUERTO RICO PROTECTA VR; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER Back to Search Results
Model Number D334VRM
Medical Device Problem Codes Failure to Charge (1085); Electrical /Electronic Property Problem (1198); Delayed Charge Time (2586)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 04/06/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
It was reported that the patients implantable cardioverter defibrillator (icd) had triggered alerts for charge circuit timeout, charge circuit inactive, and long charge time prior to battery depletion.The device was extracted and replaced.No patient complications have been reported as a result of this event.
 
Additional Manufacturer Narrative
Product event summary: the device was not returned for analysis.However, performance data collected from the device was received and analyzed.Analysis of the device memory indicated charge circuit inactive.Analysis of the device memory indicated charge circuit timeout.If information is provided in the future, a supplemental report will be issued.
 
Additional Manufacturer Narrative
The device was returned and analyzed.Analysis of the device found high internal battery resistance.Device analysis confirmed that the device did not charge efficiently with the original device battery.The device charged nominally when the battery was replaced with an external supply.No hybrid anomalies were found.Battery analysis revealed that lithium-severing was seen in turn 7.The device was returned due to an end of service (eos), excessive charge time (ect) and charge time out (cto) alerts.This charge timeout resulted from increased battery resistance induced by observed lithium-severing.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTECTA VR
Common Device Name
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER
Manufacturer (Section D)
MEDTRONIC MED REL MEDTRONIC PUERTO RICO
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
MDR Report Key7478319
Report Number3004209178-2018-09813
Device Sequence Number2183031
Product Code LWS
UDI-Device Identifier00613994714626
UDI-Public00613994714626
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
P980016
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2013
Device Explanted Year2018
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 08/28/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date11/28/2013
Device Model NumberD334VRM
Device Catalogue NumberD334VRM
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/09/2018
Initial Date Received by Manufacturer 04/06/2018
Supplement Date Received by Manufacturer05/08/2018
08/27/2018
Initial Report FDA Received Date05/01/2018
Supplement Report FDA Received Date05/09/2018
08/28/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age76 YR
Patient Weight70
-
-